Conclusions Chronic treatment with the DPP-IV inhibitors reduced myocardial infarction via the GLP-1 receptor pathway and may also involve the PKA signalling pathway. Interestingly, this effect appears to be dependent on the blood glucose levels. 内源性的GLP-1有没有改善心肌功能的研究:受试者为...